Loading...
Keywords
Last Name
Institution

Connection

Search Results to Ryan T. Fischer

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Fischer, Ryan

PropertyValue
research overview Dr. Fischer is a board-certified Pediatric Gastroenterologist and Transplant Hepatologist at Children's Mercy Hospital in Kansas City. He has a strong interest in translational research related to liver disease and transplantation, and novel therapeutics to treat disordered inflammation in the liver. Dr. Fischer’s background in the lab includes basic research in dendritic cell biology, antigen presentation and cell-based immunotherapy. In collaboration with the University of Kansas’s Department of Microbiology, Immunology and Genetics, he is working to harness the potential of regulatory T cells for the modulation of liver allograft rejection. Clinically, his focus is on the diagnosis and treatment of liver disease in children, with a great deal of time devoted to children that need or have undergone liver transplantation. The hepatology team specializes in fatty liver disease, drug-induced liver injury, progressive liver fibrosis, and liver disease related to congenital heart disease.

One or more keywords matched the following items that are connected to Fischer, Ryan

Item TypeName
Concept Genetic Therapy
Concept Endoscopy, Gastrointestinal
Concept Treatment Outcome
Academic Article Treatment of non-alcoholic fatty liver disease in children: swim at your own risk.
Academic Article Prognostic scoring indices in Wilson disease: a case series and cautionary tale.
Academic Article Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor.
Academic Article Successful rehabilitation in pediatric ultrashort small bowel syndrome.
Academic Article Intestinal transplantation in children with multiple intestinal atresias and immunodeficiency.
Academic Article Indications and efficacy of conversion from tacrolimus- to sirolimus-based immunosuppression in pediatric patients who underwent liver transplantation for unresectable hepatoblastoma.
Academic Article Barriers to ideal outcomes after pediatric liver transplantation.
Academic Article Conservative Management of Pneumatosis Intestinalis and Portal Venous Gas After Pediatric Liver Transplantation.
Academic Article Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease.
Academic Article Readiness to Change and Prospective Effects of Weight Management Programs in Pediatric Nonalcoholic Fatty Liver Disease.
Academic Article Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis.
Academic Article Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency.
Academic Article Use and safety of prophylactic endoscopy from a single center serving urban and rural children with portal hypertension.
Academic Article Irregular yellow-brown plaques on the trunk and thighs.
Academic Article Gene therapy as a potential therapeutic option for Duchenne muscular dystrophy: A qualitative preference study of patients and parents.
Academic Article Prevalence, management and efficacy of treatment in portal vein obstruction after paediatric liver transplantation: protocol of the retrospective international multicentre PORTAL registry.
Academic Article Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial.

Search Criteria
  • Therapeutic
  • endoscopy